These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 26745149

  • 21. Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy.
    Sakurada Y, Kubota T, Imasawa M, Tsumura T, Mabuchi F, Tanabe N, Iijima H.
    Retina; 2009; 29(10):1522-6. PubMed ID: 19898184
    [Abstract] [Full Text] [Related]

  • 22. Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population.
    Huang L, Meng Q, Zhang C, Sun Y, Bai Y, Li S, Deng X, Wang B, Yu W, Zhao M, Li X.
    Eye (Lond); 2015 May; 29(5):691-8. PubMed ID: 25771815
    [Abstract] [Full Text] [Related]

  • 23. Analysis of choroidal thickness and vascularity in patients with unilateral polypoidal choroidal vasculopathy.
    Lee K, Park JH, Park YG, Park YH.
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1157-1164. PubMed ID: 32037487
    [Abstract] [Full Text] [Related]

  • 24. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
    Inoue M, Balaratnasingam C, Freund KB.
    Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
    [Abstract] [Full Text] [Related]

  • 25. Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, Honda S, Nakamura M.
    Mol Vis; 2020 Nov; 26():505-509. PubMed ID: 32774081
    [Abstract] [Full Text] [Related]

  • 26. Clinical implications of pachyvessels in polypoidal choroidal vasculopathy.
    Ijuin N, Tsujinaka H, Hirai H, Jimura H, Nakao S, Yamashita M, Nishi T, Ueda T, Ogata N.
    BMC Ophthalmol; 2020 Apr 29; 20(1):170. PubMed ID: 32349707
    [Abstract] [Full Text] [Related]

  • 27. Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Nakai S, Matsumiya W, Miki A, Honda S, Nakamura M.
    Jpn J Ophthalmol; 2019 Sep 29; 63(5):389-395. PubMed ID: 31376050
    [Abstract] [Full Text] [Related]

  • 28. DIAGNOSTIC CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY BASED ON B-SCAN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND ITS INTERRATER AGREEMENT COMPARED WITH INDOCYANINE GREEN ANGIOGRAPHY.
    Fujita A, Kataoka K, Takeuchi J, Nakano Y, Horiguchi E, Kaneko H, Ito Y, Terasaki H.
    Retina; 2020 Dec 29; 40(12):2296-2303. PubMed ID: 31971919
    [Abstract] [Full Text] [Related]

  • 29. CHOROIDAL VASCULAR HYPERPERMEABILITY AS A PREDICTOR OF TREATMENT RESPONSE FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, Yeo I, Wong TY, Cheung GCM.
    Retina; 2018 Aug 29; 38(8):1509-1517. PubMed ID: 28704255
    [Abstract] [Full Text] [Related]

  • 30. Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.
    Jeong A, Lim J, Sagong M.
    Invest Ophthalmol Vis Sci; 2021 Feb 01; 62(2):29. PubMed ID: 33605985
    [Abstract] [Full Text] [Related]

  • 31. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.
    Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K.
    Acta Ophthalmol; 2013 Sep 01; 91(6):e474-81. PubMed ID: 23848133
    [Abstract] [Full Text] [Related]

  • 32. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Park SJ, Kim BH, Park KH, Woo SJ.
    Am J Ophthalmol; 2014 Dec 01; 158(6):1155-1163.e1. PubMed ID: 25127698
    [Abstract] [Full Text] [Related]

  • 33. Effects of aflibercept for ranibizumab-resistant neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Kawashima Y, Oishi A, Tsujikawa A, Yamashiro K, Miyake M, Ueda-Arakawa N, Yoshikawa M, Takahashi A, Yoshimura N.
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep 01; 253(9):1471-7. PubMed ID: 25391986
    [Abstract] [Full Text] [Related]

  • 34. Age-Related Scattered Hypofluorescent Spots on Late-Phase Indocyanine Green Angiography as Precursor Lesions of Polypoidal Choroidal Vasculopathy.
    Chen L, Zhang X, Li M, Liao N, Wen F.
    Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2102-2109. PubMed ID: 31095678
    [Abstract] [Full Text] [Related]

  • 35. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
    Bo Q, Yan Q, Shen M, Song M, Sun M, Yu Y, Rosenfeld PJ, Wang F, Sun X.
    JAMA Ophthalmol; 2019 Jun 01; 137(6):642-650. PubMed ID: 30998817
    [Abstract] [Full Text] [Related]

  • 36. Thickness of retina and choroid in the elderly population and its association with Complement Factor H polymorphism: KLoSHA Eye study.
    Ryoo NK, Ahn SJ, Park KH, Ahn J, Seo J, Han JW, Kim KW, Woo SJ.
    PLoS One; 2018 Jun 01; 13(12):e0209276. PubMed ID: 30596689
    [Abstract] [Full Text] [Related]

  • 37. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.
    Lima LH, Schubert C, Ferrara DC, Merriam JE, Imamura Y, Freund KB, Spaide RF, Yannuzzi LA, Allikmets R.
    Ophthalmology; 2010 Aug 01; 117(8):1567-70. PubMed ID: 20378180
    [Abstract] [Full Text] [Related]

  • 38. COMPARISON OF MULTICOLOR IMAGING AND COLOR FUNDUS PHOTOGRAPHY IN THE DETECTION OF PATHOLOGICAL FINDINGS IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Tan ACS, Yanagi Y, Cheung GCM.
    Retina; 2020 Aug 01; 40(8):1512-1519. PubMed ID: 31464882
    [Abstract] [Full Text] [Related]

  • 39. En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.
    Sayanagi K, Gomi F, Akiba M, Sawa M, Hara C, Nishida K.
    Br J Ophthalmol; 2015 Jan 01; 99(1):29-35. PubMed ID: 25107899
    [Abstract] [Full Text] [Related]

  • 40. Five-Year Follow-Up of Unaffected Fellow Eyes in Patients with Polypoidal Choroidal Vasculopathy.
    Kim K, Kim JM, Kim DG, Yu SY, Kim ES.
    Ophthalmologica; 2020 Jan 01; 243(3):172-177. PubMed ID: 31553990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.